CONSTELLIUM SE (CSTM)
As-reported financials and SEC filings for CONSTELLIUM SE. The latest annual period is FY2025. The latest reported quarter is Q1 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
About CONSTELLIUM SE
Constellium SE develops, manufactures, and sells specialty rolled and extruded aluminum products for industries including aerospace, space, defense, packaging, automotive, commercial transportation, and general industrial markets. The company produces semi-fabricated and fully fabricated alloyed aluminum products that meet strict performance requirements. It operates through three segments: Aerospace & Transportation, Packaging & Automotive Rolled Products, and Automotive Structures & Industry, serving a diverse customer base with advanced aluminum solutions.
Snapshot
Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.
What changed at Constellium Se
- Revenue grew 15.2% to $8.4B in FY2025, after a 6.3% decline the year before.
- Most recent quarter Q1 FY2026: revenue $2.5B, up 24.4% from Q1 FY2025.
- Free cash flow was $159M in FY2025, 1.9% of revenue.
- Net income rose 387.5% to $273M in FY2025.
Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.
Peer comparison
Where Constellium Se’s fundamentals sit among the 241 Materials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).
Constellium Se’s return on equity of 28.1% ranks in the 96th percentile of the 216 Materials companies reporting it. Constellium Se’s P/E of 6.8 ranks in the 4th percentile of the 134 peers with a meaningful P/E. Constellium Se’s long-term debt to equity of 1.96 ranks in the 90th percentile of the 165 Materials companies reporting it.
1 reported insider purchase (code P) totaling $40,588 in the last 90 days, against 1 sale totaling $280,080. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →
Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.
Recent insider activity
Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.
| Trade date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
2026-08-03 | Deslarzes Jean-ChristopheDirector | Buy | 1.5K | $27.24 | $41K |
2026-06-04 filed 2026-06-08 | Ormerod JohnDirector | Sell | 8.0K | $35.01 | $280K |
2026-05-28 filed 2026-06-01 | Becker MarcusSVP CPO | Sell | 10.4K | $34.93 | $363K |
2026-05-14 filed 2026-05-18 | Jarrett MartinSVP Chief Innovation Officer | Sell | 4.7K | $33.46 | $158K |
2026-05-14 filed 2026-05-18 | Soultz Bradley LeeDirector | Buy | 2.5K | $33.84 | $85K |
2026-05-12 filed 2026-05-13 | Piquier LudovicSVP Manuf Excellence & CTO | Sell | 1.0K | $33.57 | $34K |
2026-05-11 filed 2026-05-12 | Brun NicolasSVP PA, Comm & Sust | Sell | 26.7K | $33.85 | $902K |
2026-05-08 filed 2026-05-12 | Corre StephanePresident, AS&I | Sell | 5.0K | $33.52 | $168K |
2026-05-05 filed 2026-05-07 | Guo Jack Q.EVP & CFO | Sell | 25.2K | $32.62 | $822K |
2026-05-05 filed 2026-05-07 | Brandjes MichielDirector | Sell | 10.4K | $31.25 | $325K |
2026-05-01 filed 2026-05-05 | Hoffmann PhilippePresident, A&T | Sell | 50.0K | $31.92 | $1.6M |
2026-05-01 filed 2026-05-04 | Jurkovic Philip RyanSVP & CHRO | Sell | 48.8K | $32.01 | $1.6M |
Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.
Short interest
Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 2026-08-14 | 6.7M | +9.2% | 5.14 |
| 2026-07-31 | 6.2M | -5.8% | 3.28 |
| 2026-07-15 | 6.5M | +13.9% | 4.09 |
| 2026-06-30 | 5.7M | -4.9% | 2.69 |
| 2026-06-15 | 6.0M | -3.7% | 2.98 |
| 2026-05-29 | 6.3M | +3.0% | 2.39 |
| 2026-05-15 | 6.1M | -8.4% | 3.01 |
| 2026-04-30 | 6.6M | -10.9% | 2.75 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.
Income statement (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue | $8.45B | $7.33B | $7.83B | $8.53B |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | $273.0M | $56.0M | $152.0M | $308.0M |
| Diluted EPS | $1.92 | $0.38 | $1.03 | $2.10 |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Balance sheet (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Cash and equivalents | $120.0M | $141.0M | $223.0M | $176.0M |
| Current assets | $2.32B | $1.83B | $1.99B | — |
| Total assets | $5.35B | $4.73B | $4.93B | — |
| Current liabilities | $1.80B | $1.45B | $1.56B | — |
| Long-term debt | $1.91B | $1.88B | $1.89B | — |
| Total liabilities | $4.38B | $4.01B | $4.19B | — |
| Total equity | $971.0M | $727.0M | $742.0M | $603.0M |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Cash flow (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Operating cash flow | $489.0M | $301.0M | $432.0M | $365.0M |
| Capital expenditure | $330.0M | $413.0M | $366.0M | $289.0M |
| Free cash flow | $159.0M | $-112.0M | $66.0M | $76.0M |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Quarterly trend (as reported)
| Quarter | Revenue | Revenue YoY | Net income | Diluted EPS |
|---|---|---|---|---|
| Q1 FY2026 | $2.46B | 24.4% | $199.0M | $1.42 |
| Q4 FY2025 | $2.20B | 27.9% | $112.0M | $0.79 |
| Q3 FY2025 | $2.17B | 20.2% | $88.0M | $0.62 |
| Q2 FY2025 | $2.10B | 8.9% | $36.0M | $0.25 |
| Q1 FY2025 | $1.98B | 5.3% | $37.0M | $0.26 |
| Q4 FY2024 | $1.72B | — | $-48.0M | $-0.33 |
| Q3 FY2024 | $1.80B | — | $7.0M | $0.05 |
| Q2 FY2024 | $1.93B | — | $76.0M | $0.51 |
Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.
Company facts
Selected SEC filings
Largest Materials peers
Monitor CSTM
Get an alert when Constellium Se files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor CSTM freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.